Bowen Hanes & CO Inc Vertex Pharmaceuticals Inc Transaction History

Bowen Hanes & CO Inc

$3.8 Billion
Q3 2024

A detailed history of Bowen Hanes & CO Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 178,884 shares of VRTX stock, worth $72.5 Million. This represents 2.19% of its overall portfolio holdings.

Number of Shares

178,884

Previous 179,504 0.35%

Holding current value

$72.5 Million

Previous $84.1 Million 1.12%

% of portfolio

2.19%

Previous 2.33%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $285,200 - $313,583	-620 Reduced 0.35%	178,884 $83.2 Million
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $679,561 - $839,966	1,730 Added 0.97%	179,504 $84.1 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $1.62 Million - $1.77 Million	3,974 Added 2.29%	177,774 $74.3 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $548,800 - $657,088	-1,600 Reduced 0.91%	173,800 $70.7 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $713,559 - $764,790	2,110 Added 1.22%	175,400 $61 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $521,937 - $584,170	-1,660 Reduced 0.95%	173,290 $61 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $73,639 - $84,006	-260 Reduced 0.15%	174,950 $55.1 Million
Q4 2022 Feb 09, 2023	SELL	$285.76 - $321.48 $1.66 Million - $1.86 Million	-5,800 Reduced 3.2%	175,210 $50.6 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $2.88 Million - $3.21 Million	-10,515 Reduced 5.49%	181,010 $52.4 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $259,630 - $323,267	-1,105 Reduced 0.57%	191,525 $54 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $329,915 - $388,845	-1,490 Reduced 0.77%	192,630 $50.3 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $2.74 Million - $3.46 Million	15,475 Added 8.66%	194,120 $42.6 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $5.2 Million - $5.81 Million	28,645 Added 19.1%	178,645 $32.4 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $3.56 Million - $4.2 Million	19,000 Added 14.5%	150,000 $30.2 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $901,920 - $1.18 Million	-4,000 Reduced 2.96%	131,000 $38 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $2.5 Million - $3.36 Million	-15,000 Reduced 10.0%	135,000 $29.6 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $2.28 Million - $2.88 Million	-15,000 Reduced 9.09%	150,000 $24.9 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $24.4 Million - $26.8 Million	165,000	165,000 $25.1 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $104B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.

Account

Bowen Hanes & CO Inc Vertex Pharmaceuticals Inc Transaction History